BMC Psychiatry (Jul 2024)

Adherence to clinical practice guidelines for using electroconvulsive therapy in elderly depressive patients

  • Antoine Yrondi,
  • Olivier Blanc,
  • Loic Anguill,
  • Christophe Arbus,
  • Ludivine Boudieu,
  • Marie-Camille Patoz,
  • Adeline Arnould,
  • Thomas Charpeaud,
  • Jean-Baptiste Genty,
  • Racan Abidine,
  • Maximilien Redon,
  • Romain Rey,
  • Bruno Aouizerate,
  • Djamila Bennabi,
  • Wissam El-Hage,
  • Bruno Etain,
  • Jérôme Holtzmann,
  • Marion Leboyer,
  • Fanny Molière,
  • Raphaelle Marie Richieri,
  • Florian Stéphan,
  • Guillaume Vaiva,
  • Anne Sauvaget,
  • Emmanuel Poulet,
  • Emmanuel Haffen,
  • Philippe Courtet,
  • Philippe Fossati,
  • Pierre-Michel Llorca,
  • Ludovic Samalin

DOI
https://doi.org/10.1186/s12888-024-05933-7
Journal volume & issue
Vol. 24, no. 1
pp. 1 – 8

Abstract

Read online

Abstract Objectives Electroconvulsive therapy (ECT) is one of the most effective treatments in mood disorders, mainly in major depressive episode (MDE) in the context of either unipolar (MDD) or bipolar disorder (BD). However, ECT remains a neglected and underused treatment. Older people are at high risk patients for the development of adverse drug reactions. In this context, we sought to determine the duration of MDEs and the number of lines of treatment before the initiation of ECT in patients aged 65 years or over according to the presence or absence of first-line indications for using ECT from international guidelines. Methods In this multicenter, retrospective study including patients aged 65 years or over with MDEs in MDD or BD who have been treated with ECT for MDEs, data on the duration of MDEs and the number of lines of treatment received before ECT were collected. The reasons for using ECT, specifically first-line indications (suicidality, urgency, presence of catatonic and psychotic features, previous ECT response, patient preference) were recorded. Statistical comparisons between groups used standard statistical tests. Results We identified 335 patients. The mean duration of MDEs before ECT was about 9 months. It was significantly shorter in BD than in MDD- about 7 and 10 months, respectively. The co-occurrence of chronic medical disease increased the duration before ECT in the MDD group. The presence of first-line indications for using ECT from guidelines did not reduce the duration of MDEs before ECT, except where there was a previous response to ECT. The first-line indications reduced the number of lines of treatment before starting ECT. Conclusion Even if ECT seems to be a key treatment in the elderly population due to its efficacity and safety for MDEs, the delay before this treatment is still too long.

Keywords